Dynamic Modeling of the Angiogenic Switch and Its Inhibition by Bevacizumab

Figure 7

Volume trajectories of the model (living volume , unsupported volume , necrotic volume , and total volume , corresponding to subfigures (a), (b), (c), and (d), resp.) in the case of various therapies.

(a)

(b)

(c)

(d)